Streetbeat News

Analyst Ratings

ARM

Arm Holdings shares rose following Raymond James' initiation of coverage with an Outperform rating and a $160 price target.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:17 pm

APP

Apploving shares are experiencing an upward trend following BTIG's decision to increase its price target from $114 to $150.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:14 pm

VST

Vistra shares rose following Jefferies' initiation of coverage with a Buy rating and a price target of $99.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:13 pm

SHO

Wells Fargo has upgraded Sunstone Hotel Invts (NYSE:SHO) from Underweight to Equal-Weight, setting a price target of $10.5.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:12 pm

MRNA

RBC Capital analyst Luca Issi maintains a Sector Perform rating on Moderna (NASDAQ:MRNA) but lowers the price target from $90 to $75.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:12 pm

XHR

Wells Fargo has upgraded Xenia Hotels & Resorts (NYSE:XHR) from Equal-Weight to Overweight, while lowering the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:09 pm

MSDL

RBC Capital analyst Kenneth Lee has reiterated an Outperform rating on Morgan Stanley Direct (NYSE:MSDL) and maintained a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:09 pm

MPW

Medical Properties Trust shares rose following an upgrade to a Buy rating by Colliers Securities, with a new price target of $6.5. Truist Securities also increased its price target from $5 to $6.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:08 pm

BNTX

Wealthy investors have taken a bearish stance on BioNTech (NASDAQ:BNTX) through options trading, with 63% of trades being bearish. The options activity suggests a price target range of $95 to $200. Despite a recent 6.46% price increase to $111.78, analysts have mixed ratings, with a consensus target price of $105.67.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 2:04 pm

USB

RBC Capital analyst Gerard Cassidy has reiterated an Outperform rating for U.S. Bancorp (NYSE:USB) and maintained a price target of $48.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 2:04 pm